Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2020 December;111(6) > Minerva Medica 2020 December;111(6):619-22

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

LETTERS TO THE EDITOR   

Minerva Medica 2020 December;111(6):619-22

DOI: 10.23736/S0026-4806.20.06662-8

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Health-related quality of life: validation of the Kazakh version of the EORTC QLQ-BR23 in breast cancer patients

Almagul ZHABAGINA 1 , Tasbolat ADYLKHANOV 1, Nailya KABILDINA 2, Nurtas TURSYNOV 3, Nurlan IBRAIMKHAN 3, Vladimir KULISHOV 2, Meirambek ASKAROV 4, Kuantkan ZHABAGIN 1, Nazym KUDAIBERGENOVA 5, Gulzhanat JAKOVA 6, Sabit ZHUSSUPOV 7, Daniyar ALDYNGUROV 8, Daniyar RAISSOV 8, Anel BEISENAYEVA 9

1 Department of Clinical and Radiation Oncology, Semey State Medical University, Semey, Kazakhstan; 2 Department of Oncology and Radiology, Karaganda State Medical University, Karaganda, Kazakhstan; 3 Department of Neurosurgery and Neuropathology, Karaganda State Medical University, Karaganda, Kazakhstan; 4 Department of Surgery Disease, Karaganda State Medical University, Karaganda, Kazakhstan; 5 Department of Infectious Diseases and Immunology, Semey State Medical University, Semey, Kazakhstan; 6 Department of Surgery #1, Pavlodar Branch of Semey State Medical University, Semey, Kazakhstan; 7 Almaty Regional Oncological Hospital, Almaty, Kazakhstan; 8 Department of Radiology and Nuclear Medicine, Semey State Medical University, Semey, Kazakhstan; 9 Department of Oncology, Karaganda State Medical University, Karaganda, Kazakhstan



inizio pagina